Search / Trial NCT06614660

Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer

Launched by FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Sep 24, 2024

Trial Information

Current as of October 07, 2024

Unknown status

Keywords

Colorectai Cacner Imaging Genomics Metabolomics Genomics Prognosis

Description

This experiment is a prospective cohort study and is expected to include 300 patients who were diagnosed with colorectal cancer and underwent radical colorectal cancer surgery at the First Affiliated Hospital of Chongqing Medical University. 1. Data collection before and after surgical treatment 1. Study subjects: patients diagnosed with colorectal cancer and voluntarily undergoing radical colorectal cancer surgery in the First Affiliated Hospital of Chongqing Medical University will be included; preoperative imaging images will be collected before surgery, and 2 ml of blood specimens wil...

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • * met the diagnostic criteria for gastrointestinal tumours;
  • * age \>18 years;
  • * planned to undergo surgery for gastrointestinal tumours according to the guidelines;
  • * signed an informed consent form; and e) agreed to undergo a biopsy in order to collect tissue from the tumour lesion.
  • Exclusion criteria:
  • * contraindications to imaging;
  • * withdrawal from the study cohort midway;
  • * metastatic foci in the liver, lung or other distant organs confirmed by CT, MRI or ultrasound imaging;
  • * gastrointestinal tumours combined with haemorrhage, obstruction or perforation;
  • * women who were pregnant, breastfeeding or planning to become pregnant during the study period.

About First Affiliated Hospital Of Chongqing Medical University

The First Affiliated Hospital of Chongqing Medical University is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and education. As a prominent sponsor of clinical trials, the hospital is committed to conducting high-quality, ethically-driven studies that contribute to the understanding and treatment of various medical conditions. With a robust infrastructure and a team of experienced researchers and healthcare professionals, the institution fosters collaboration across disciplines to enhance patient care and improve health outcomes. Its strategic focus on translational medicine underscores the hospital's role in bridging the gap between laboratory discoveries and clinical applications, ultimately benefiting patients and the broader medical community.

Locations

Chongqing, Chongqing, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0